Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia
โ Scribed by Kebede Hussein; Balkrishna Jahagirdar; Pankaj Gupta; Linda Burns; Karen Larsen; Daniel Weisdorf
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 156 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The strategy named double induction (DI) in acute myeloid leukemia (AML) consists of two courses of chemotherapy irrespective of the degree of cytoreduction in the bone marrow (BM) after the first course, unless severe complications prohibit its application. We describe treatment result
Background. Many pediatric chemotherapy protocols for treatment of ALL require a bone marrow examination at day 7 or day 14 after initiation of therapy. The usefulness of a bone marrow biopsy, in addition to an aspirate, has been a frequently asked question. Procedure. This study addresses the eval